4Boehme MWJ, Raeth U, Galle PR, et al. Serum thrombomodulin-a reliable marker of disease activity in systemic lupus erythematosus (SLE): advantage over established serological parameters to indicate disease activity. Clin Exp Immunol, 2000, 119:189-195.
5Thomas GN, Tam LS, Tomlinson B, et al. Accelerated atherosclerosis in patients with systemic lupus erythematosus: a review of the causes and possible prevention. HMKJ, 2002, 8: 26-32.
6Renaudineau Y, Dugue C, Dueymes M, et al. Antiendothelial cell antibodies in systemic lupus erythematosus. Autoimmun Rev,2002, 1: 365-372.
7Levy GA, Liu MF, Ding JW, et al. Molecular and functional analysis of the human prothrombinase gene (hfgl2) and its role in viral hepatitis. Am J Pathol, 2000, 156: 1217-1225.
8Chan CW, Chan MW, Liu MF, et al. Kinetic analysis of a unique direct prothrombinase, fgl2, and identification of a serine residue critical for the prothrombinase activity. J Immunol, 2002, 168:5170-5177.
9Clark DA, Chaouat G, Arck PC, et al. Cytokine-dependent abortion in CBA × DBA/2 mice is mediated by the procoagulant fgl2prothrombinase (correction of prothombinase). J Immunol, 1998,160: 545-549.
10Kim PO, Levy GA, Craig M, et al. Immune responses during smallintestine allograft rejection: correlation between procoagulant activity and histopathology. Transplant Proc, 1990, 23: 2477.
